Radiation May Not Be Necessary For Some Hodgkin's Children

According to the findings of a small study published in the Journal of the American Medical Association, some children diagnosed with early-stage Hodgkin's lymphoma who respond to induction chemotherapy might not require subsequent radiotherapy treatment.

If so, this would bode well for those patients, since radiation presents its own dangers for their current and future health. The study will require confirmation in larger trials, but could present the possibility of avoiding the risks of secondary cancer later in life possibly caused by radiation.

Doctors are always trying to cut down on the long-term side effects from treatment, especially in Hodgkin's patients since treatment is often successful and doctors have learned enough that they can now seek ways to reduce future harm.

This study was carried out at St. Jude Children's Research Hospital and involved 88 children with early-stage HL.

After two cycles of VAMP chemotherapy (adriamycin, methotrexate, vinblastine and prednisone), 47 children had a complete response, and received two more cycles of chemo but did not receive radiation.

The 41 patients who did not achieve a complete response received the other two cycles of chemo along with radiotherapy.

After an average seven years of follow-up, there was no significant difference in survival between the two groups of children.

"This study adds to evidence that it is possible to omit radiation even in patients treated with a less intense chemotherapy regimen and still achieve excellent long-term survival," added Dr Monika Metzger, from St. Jude Children's Research Hospital.

Source: JAMA

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap